Joel Isaacson & Co., LLC Astrazeneca PLC Transaction History
Joel Isaacson & Co., LLC
- $2.88 Billion
- Q4 2025
A detailed history of Joel Isaacson & Co., LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 4,735 shares of AZN stock, worth $423,309. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,735
Previous 4,695
0.85%
Holding current value
$423,309
Previous $360,000
17.5%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,554Shares Held
503MCall Options Held
5.54MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...